Concepedia

Author

Christiane Pott

University of LübeckORCID

Also Known As

C Pott, C. Pott, Christiane Pott, David Gonzalez, Kostas Stamatopoulos, Nikos Darzentas, Pott C., Pott, Christiane

330

Publications

11.4K

Citations

52

H-Index

77

Concepts

All Affiliations

University of LübeckUniversity Hospital Schleswig-HolsteinChristian-Albrechts-Universität zu KielLudwig-Maximilians-Universität MünchenHeidelberg University
CP

About

Christiane Pott is an author at University of Lübeck specializing in medicine, immunology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

24

38

3.3K

2

Cell Biology

11

11

965

3

Health Sciences

9

9

659

4

Engineering

2

2

326

5

Natural Sciences

1

1

28

Christiane Pott

×

104

Publications

9.9K

Citations

47

H-Index

YearCitations

A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling

Michael Hummel, Stefan Bentink, Hilmar Berger,

New England Journal of Medicine

2006

1K

Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry

Alessandro Pastore, Vindi Jurinović, Robert Kridel,

The Lancet Oncology

2015

608

Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia

Monika Brüggemann, Thorsten Raff, Thomas Flohr,

Blood

2005

534

Maintenance therapy with rituximab leads to a significant prolongation of response duration after salvage therapy with a combination of rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) in patients with recurring and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low Grade Lymphoma Study Group (GLSG)

Roswitha Forstpointner, Michael Unterhalt, Martin Dreyling,

Blood

2006

464

Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma

Constantine S. Tam, Mary Ann Anderson, Christiane Pott,

New England Journal of Medicine

2018

417

Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network

Olivier Hermine, Eva Hoster, Jan Walewski,

The Lancet

2016

390

Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders

Marco Ladetto, Monika Brüggemann, Luigia Monitillo,

Leukemia

2013

303

Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults

Itziar Salaverría, Claudia Philipp, Ilske Oschlies,

Blood

2011

287

Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study

Christiane Pott, Eva Hoster, Marie‐Hélène Delfau‐Larue,

Blood

2009

267

Molecular Subsets of Mantle Cell Lymphoma Defined by the <i>IGHV</i> Mutational Status and SOX11 Expression Have Distinct Biologic and Clinical Features

Alba Navarro, Guillem Clot, Cristina Royo,

Cancer Research

2012

249

Page 1